Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update evaluating the efficacy and safety of cANn cannabidiol oral solution for joint pain associated with adjuvant endocrine therapy in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cANn cannabidiol Oral Solution (cannabidiol)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Breast Cancer Stage I, Breast Cancer Stage II | Phase 3 | Status: NOT_YET_RECRUITING